medigraphic.com
ISSN 1405-8871 (Print)

2025, Number 1

<< Back Next >>

Aten Fam 2025; 32 (1)

Description of the Predominant Clinical Picture in Dengue-COVID-19 Coinfection: Review of Reported Cases

Salazar-Alcaraz G, Roman-Morales YE, García-Morales G, Gil-Ojeda R, Garduño-Orbe B

Language: Spanish
References: 59
Page: 59-68
PDF size: 282.04 Kb.


ABSTRACT

Objective: to describe the clinical features in dengue-COVID-19 coinfection in published cases or case series. Methods: we searched PubMed, Scielo and Google Scholar for reported cases of denguecovid- 19 coinfection, MeSH terms of “coinfection-coinfection”, “Dengue”, “covid-19” and “SARS-COV-2” were used. Dengue-COVID-19 coinfection publications from January 2020 to August 2023 were included. We excluded duplicate, restricted access, retracted articles and those in which the viruses were not laboratory confirmed. Those in which there was a third acute infectious process, non-simultaneous coinfection and when the result of one of the viruses was a false positive were eliminated. Results: 57 cases were included, the predominant symptoms were fever with 96.5%, general malaise in 54.4% and myalgias in 49.1%. Alarm data such as edema, hepatomegaly, pleural effusion and encephalitis were more frequent in the 0 to 19 years age group. Seven deaths were reported in patients older than 19 years of age. Symptoms associated with death were dyspnea and lethargy. Conclusion: the predominant symptoms identified in the cases studied were fever, malaise and myalgias, which are present in both diseases. In dengue endemic areas, the treating physician should be aware of dengue-COVID-19 coinfection in order to provide adequate management and avoid complications due to this cause.


REFERENCES

  1. Organización Mundial de Salud. Dengue – SituaciónMundial [Internet]. [Citado 02 de marzo de 2024]. Disponible en: https://www.who.int/es/emergencies/disease-outbreaknews/item/2023-DON498

  2. Organización Panamericana de Salud. Situaciónepidemiológica del dengue, la chikunguñay el Zika en las Américas, 2023 [Internet]. [Citado21 de diciembre de 2023]. Disponible en:https://www.paho.org/es/documentos/situacionepidemiologica-dengue-chikunguna-zika-americas-2023

  3. Organización Mundial de Salud. [Internet].[Citado 21 de diciembre de 2023]. Disponibleen: https://www.who.int/es/news/item/05-05-2023-statement-on-the-fifteenthmeeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic

  4. Organización Panamericana de Salud. Situacióndel SARS CoV2 - Región de las Américas, 2023[Internet]. [Citado 03 de enero de 2024]. Disponibleen: https://www.paho.org/en/covid-19-weeklyupdates-region-americas?topic=4951&d%5Bmin%5D=2023-01-01&d%5Bmax%5D=2023-12-31

  5. Secretaria de Salud. Panorama epidemiológico dedengue. Semana epidemiológica 52 de 2023 [Internet].[Citado 02 de marzo de 2024]. Disponibleen: https://www.gob.mx/cms/uploads/attachment/file/878786/Pano_dengue_52_2023.pdf

  6. El-Qushayri AE, Kamel AMA, Reda A, Ghozy S.Does dengue and COVID-19 co-infection haveworse outcomes? A systematic review of currentevidence. Rev Med Virol. 2022;32(5):e2339.

  7. Agudelo-Rojas OL, Rebellón-Sánchez DE, LlanosTorres J, Zapata-Vásquez IL, Rodríguez S, Robles-Castillo S, et al. Co-Infection between DengueVirus and SARS-CoV-2 in Cali, Colombia. Am JTrop Med Hyg. 2023;109(3):536-541.

  8. Prapty CNBS, Rahmat R, Araf Y, Shounak SK,Noor-A-Afrin, Rahaman TI, et al. SARS-CoV-2and dengue virus co-infection: Epidemiology,pathogenesis, diagnosis, treatment, and management.Rev Med Virol. 2023;33(1):e2340.

  9. Tsheten T, Clements ACA, Gray DJ, AdhikaryRK, Wangdi K. Clinical features and outcomes ofCOVID-19 and dengue co-infection: a systematicreview. BMC Infect Dis. 2021;21(1):729.

  10. Panda PK, Sharawat IK. COVID-19 and/with dengueinfection: A curse in an overburdened healthcaresystem. Trop Doct. 2021;51(1):106-108.

  11. Ridwan R. COVID-19 and dengue: a deadly duo.Trop Doct. 2020;50(3):270-272.

  12. Organización Mundial de Salud. Enfermedad porcoronavirus (COVID-19) [Internet]. [Citado 02de marzo de 2024]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/coronavirus-disease-(covid-19)

  13. Ravindra P, Wilson W, Macharla A, Umakanth S,Saravu K, Gupta N. Two viruses in a pod: a caseseries of coinfection of COVID-19 with dengue.Oxf Med Case Reports. 2022; 2022(10):omac112.

  14. Kazi MA, Ghosh S, Roychowdhury S, Giri PP,Sarkar M. A Case Study of Dual Infection ofDengue and COVID-19: Presenting as MultiorganDysfunction in an Infant. J Trop Pediatr.2022;67(1):fmaa080.

  15. Tiwari L, Shekhar S, Bansal A, Kumar P. COVID-19 with dengue shock syndrome in a child:coinfection or cross-reactivity? BMJ Case Rep.2020;13(12):e239315.

  16. Adarsh MB, Abraham A, Kavitha P, NandakumarMM, Vaman RS. Severe Thrombocytopenia in COVID-19: A Conundrum in Dengue-endemic Areas.Indian J Crit Care Med. 2021;25(4):465-466.

  17. Gupta S, Arora S, Gupta M, Jesrani G. DengueMyocarditis Complicated by COVID-19:A Case Report on Dual Viral Infection. Cureus.2021;13(8):e17076.

  18. Krishna A, Singh PP, Vardhan H, Kumar O. Coinfectionof COVID-19 with dengue fever andacute graft dysfunction in a kidney transplantrecipient - A case report. Indian J Transplant.2020;14:363-365.Coinfección dengue-covid-19Aten Fam. 2025;32(1):59-68. http://dx.doi.org/10.22201/fm.14058871p.2025.1.90133

  19. Alam A, Sudarwati S, Hakim DDL, MahdianiS. Case Report: Severe COVID-19 and Denguein an Indonesian Infant. Am J Trop Med Hyg.

  20. 2021;104(4):1456-1460.20. Kembuan GJ. Dengue serology in Indonesian COVID-19 patients: Coinfection or serological overlap?IDCases. 2020;22:e00927.

  21. Masyeni S, Santoso MS, Widyaningsih PD, AsmaraDW, Nainu F, Harapan H, et al. Serologicalcross-reaction and coinfection of dengue and COVID-19 in Asia: Experience from Indonesia. Int JInfect Dis. 2021;102:152-154.

  22. Irwinda R, Wibowo N, Prameswari N. Cytokinesstorm in COVID-19 with dengue co-infection inpregnancy: Fatal maternal and fetal outcome. IDCases.2021;26:e01284.

  23. Indrarto W. Coinfection of COVID-19 and dengue:a case report. J Med Sci. 2023;55(1): 79-85.

  24. Theodora A, Suryana K. Managing severe thrombocytopeniain co-infection of COVID-19 anddengue hemorrhagic fever: a case report. Int J AdvMed. 2022;9(8):889-893

  25. Arisova IWWA, Rena NMRA, Somia IKA. Covid-19 Coinfection and Dengue Fever in Patientswith Myelodysplastic Syndrome: A Case Report.IJSCIA. 2023;4(4): 664-666.

  26. Estofolete CF, Machado LF, Zini N, LuckemeyerGD, Moraes MM, Dos Santos TMIL, et al.Presentation of fatal stroke due to SARS-CoV-2and dengue virus coinfection. J Med Virol.2021;93(3):1770-1775.

  27. Bicudo N, Bicudo E, Costa JD, Castro JALP, BarraGB. Co-infection of SARS-CoV-2 and denguevirus: a clinical challenge. Braz J Infect Dis.2020;24(5):452-454.

  28. Quental KN, Leite AL, Feitosa ADNA, OliveiraZNP, Tavares LVS, Tavares WGS, et al. SARSCoV-2 co-infection with dengue virus in Brazil: Apotential case of viral transmission by a health careprovider to household members. Travel Med InfectDis. 2021; 40:101975.

  29. Pereira SM, do Nascimento CT, Ferro RS, FloresEF, Maldonado Bertacco EA, Fonseca EdS, et al.Double Trouble: Dengue Followed by COVID-19Infection Acquired in Two Different Regions: ADoctor’s Case Report and Spatial Distribution ofCases in Presidente Prudente, São Paulo, Brazil.Trop. Med. Infect. Dis. 2021;6(3):156.

  30. Amin MA, Islam MT, Khan II, Khan ZH, QadriF, Khan AI. COVID-19 and dengue infectionin Bangladesh: A case of coinfection wherehemoptysis as first presentation. Clin Case Rep.2022;10(1):e05252.

  31. Ferdous A, Hossain MM, Afrin M, Shirin M.Dengue With COVID-19: Associated with Coinfectionand Multiple Organ Dysfunction in aChild. Cureus. 2021;13(12): e20763.

  32. Hossain MR, Sarmin M, Rahman H, Shahrin L,Nyma Z, Ahmed T, et al. SARS-CoV-2 and denguevirus coinfection in an adult with beta-thalassemia(trait): A case report from Bangladesh withliterature review. Heliyon. 2021;7(10):e08229

  33. Hossain HT, Tasnim R, Khatun H, Noor N, RishadMM, Islam QT. Covid-19 and dengue coinfectionin a young girl: a case report. J Medicine.2022;33:104-108.

  34. Ferdous A, Hossain MM, Afrin M, Shirin M. Coinfectionwith Dengue and COVID-19: A CaseReport of Multiorgan Dysfunction in a Child.IOSR-JDMS. 2021; 20(12):25-29.

  35. Malibari AA, Al-Husayni F, Jabri A, Al-AmriA, Alharbi M. A Patient with Dengue Feverand COVID-19: Coinfection or Not? Cureus.2020;12(12):e11955.

  36. Al-Nazawi AM, Al-Zahrani AA, Qadir A, AlghamdiR, Tambo E, Alsahafi A. Case report: A fataloutcome from co-infection of COVID-19 anddengue in the western region of Jeddah, Saudi Arabia.Front Public Health. 2022;10:942381.

  37. Radisic MV, Piro MA, Mori I, Rotryng F, SantamarinaJF. SARS-CoV-2 and Dengue virus Co-infection.A Case Report. Infez Med. 2020;28(3):416-419.

  38. Rosso MV, Clemant T, Quiroga CAF, García S,Mulinaris EO. SARS-CoV-2 and dengue viruscoinfection involving the skin of an Argentinianfemale. Int J Womens Dermatol. 2021;7(5):824-825.

  39. Salvo CP, Di Lella N, Solveyra López F, Hugo J,Gigena Zito J, Vilela A. Coinfección dengue ySARS-COV-2 en paciente HIV positivo. Medicina(B Aires). 2020;80 Suppl 6:94-96.

  40. Betancur-Pérez T, Ramírez-Urrea SI, Angulo-GarcíaVC, Beltrán-Miranda AP, Galván-Suárez MM,Sayas-Herazo ME, et al. Covid-19 and DengueCoinfection: Case Report. Jap J Clin & Med Res.2021;1(3):1-2.

  41. Agudelo Rojas OL, Tello-Cajiao ME, Rosso F.Challenges of dengue and coronavirus disease2019 coinfection: two case reports. J Med CaseRep. 2021;15(1):439.

  42. Prapty CNBS, Ahmed N, Araf Y, Yang Z, Zhai J,Hosen MJ, et al. Coinfection of COVID-19 andDengue: A Case Report. Front Med (Lausanne).2022;9:872627.

  43. Saipen A, Demot B, De León L. Dengue–COVID-19 coinfection: the first reported case in thePhilippines. WPSAR. 2021;12(1): 35-39.

  44. Epelboin L, Blondé R, Nacher M, Combe P, ColletL. COVID-19 and dengue co-infection in a returningtraveller. J Travel Med. 2020;27(6):taaa114.

  45. Verduyn M, Allou N, Gazaille V, Andre M, DesrocheT, Jaffar MC, et al. Co-infection of dengueand COVID-19: A case report. PLoS Negl TropDis. 2020;14(8):e0008476.

  46. Zepeda-Carrillo EA, Soria Saavedra FM, MercadoVillegas MB, López Alvarado A, Regla-Nava JA,Torres-Valadez R. SARS-CoV-2 and Dengue VirusCoinfection in a Mexican Pediatric Patient: A CaseReport from Early Molecular Diagnosis. Pathogens.2022;11(11):1360.

  47. Reyes-Ruiz JM, Campuzano-Vences R, Osuna-Ramos JF, De Jesús-González LA, Pérez-MéndezMJ, González-González C, et al. Case Report:Extrapulmonary Manifestations of COVID-19and Dengue Coinfection. Am J Trop Med Hyg.2021;105(2):363-367.

  48. Saw YT, Lee HG. Concurrent COVID-19 anddengue with hyperferritinaemia: A case report.Med J Malaysia. 2021;76(6):918-920.

  49. Nair S. COVID-19 Pneumonia and Dengue FeverCoinfection in an Individual from Southeast Asia.Cureus. 2021;13(10): e18846.

  50. Hilmy AI, Dey RK, Imad HA, Yoosuf AA,Nazeem A, Latheef AA. Coronavirus disease 2019and dengue: two case reports. J Med Case Rep.2021;15(1):171.

  51. Valdés-González JL, Valdés-González EM, Solis-Cartas U, Sigcho-Romero SF. Dengue, COVID-19 y gota, una asociación infrecuente. RevCuba Reumatol. 2020; 22(Suppl 1):e871.

  52. Giacomelli A, Pagani G, Covizzi A, Antinori S,Cattaneo D, Gervasoni C. The importance of anamnesisin differential diagnosis: a case of SARSCoV-2 and dengue virus co-infection. Infez Med.2021;29(1):114-116.

  53. Montiel Jarolin D, Barreto V, Fariña J, Jaluf M,Jazmín C, Jarolin M. Reporte de un caso: Coinfeccióndengue-COVID-19. Rev Cient Cienc Salud.2021; 3(2):95-101.

  54. Moreno-Soto AA, Espinoza Venegas LA, SilesMontoya CA, Melendez Maron M. Coinfecciónde la COVID 19 y Virus del Dengue: Reporte deCaso. Acta Med Peru. 2021; 38(2):123-126.

  55. Ratnarathon AC, Pongpirul K, Pongpirul WA,Charoenpong L, Prasithsirikul W. Potential dualdengue and SARS-CoV-2 infection in Thailand: Acase study. Heliyon. 2020;6(6): e04175.

  56. Nasomsong W, Luvira V, Phiboonbanakit D. CaseReport: Dengue and COVID-19 Coinfection inThailand. Am J Trop Med Hyg. 2020;104(2):487-489.

  57. Instituto Mexicano del Seguro Social. Listado deauxiliaries de diagnóstico [Internet]. [Citado 2024Oct 01]. Disponible en: https://www.imss.gob.mx/profesionales-salud/cuadros-basicos/diagnostico

  58. Lustig Y, Keler S, Kolodny R, Ben-Tal N, Atias-Varon D, Shlush E, et al. Potential AntigenicCross-reactivity Between Severe Acute RespiratorySyndrome Coronavirus 2 (SARS-CoV-2)and Dengue Viruses. Clin Infect Dis. 2021;73(7):e2444-e2449.

  59. Guzman MG, Alvarez M, Halstead SB. Secondaryinfection as a risk factor for dengue hemorrhagicfever/dengue shock syndrome: an historical perspectiveand role of antibody-dependent enhancementof infection. Arch Virol. 2013;158(7):1445-1459.




2020     |     www.medigraphic.com